Latest filing published 17 Jul 2026 for Pharmala Biotech Holdings Inc., €3,961.
All filings by Fraser Macdonald on record concern Pharmala Biotech Holdings Inc. Between 22 March 2021 and 16 July 2026, the trades on record add up to 11 filings.
In open-market terms, that means 1 purchase worth €253 on one side and 6 sales worth €23k on the other. Netting one side against the other leaves €23k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 option exercises. Since January 2026: no purchases and 6 sales on the market.
The record was last updated on 17 July 2026 with an open-market sale (€3,961) in Pharmala Biotech Holdings Inc. The latest purchase dates back some time: it was published 1,730 days ago, on 31 January 2022. Filings reach the SEDI feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations